Effectiveness of a Standardized Healthcare Education Program in People With Heart Failure
Heart failure is a chronic illness with a high prevalence and impact on the quality of life of the people who experience it, associated with high hospital taxes and mortality. Beyond the results of traditional clinics, factors such as health literacy, therapeutic adherence and self-healing play a key role in the evolution of this pathology. Various studies show that inadequate health literacy levels lead to better control of malaria, more re-entry and a lower quality of life.
The objective of this research is to evaluate the effectiveness of a standard health education care program, led by nurses specialized in heart failure, initiating discharge from hospitals and with structured follow-up during the first few months afterward, compared to conventional care. It is intended to analyze its impact on health literacy, therapeutic adherence, self-healing, and quality of life, as well as explore the associated social determinants.
It will last a random clinical trial between two groups (intervention and control) at the Heart Failure Unit of the Figueres Hospital. The participants will be adults admitted for decompensation of heart failure and will be followed for 12 months, with evaluations at admission, at 6 months and at any time after discharge. It is important to serve validated instruments to measure quality of life, health literacy and therapeutic adherence.
It is hoped that the intervention will improve the quality of life and health literacy of people with heart failure, contributing to more equitable care, centered on the person and oriented towards better health outcomes.
Aperçu de l'étude
Statut
Statut
Les conditions
Les conditions
Intervention / Traitement
Intervention / Traitement
Type d'étude
Type d'étude
Inscription (Estimé)
Inscription
Phase
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
Coordonnées de l'étude
- Nom: Clara Vargas Farber, RN Nurse
- Numéro de téléphone: +34972592005
- E-mail: cvargas@salutemporda.cat
Sauvegarde des contacts de l'étude
- Nom: Silvia Zuheros Santó, Administrative
- E-mail: szuheros@salutemporda.cat
Critères de participation
Critère d'éligibilité
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- People who are admitted for decompensated heart failure, and who are going to undergo post-discharge monitoring at the Heart Failure Unit of the Figueres Hospital.
- have signed the informed consent.
Exclusion Criteria:
- People diagnosed with cognitive impairment or dementia.
- Institutionalized people.
- Foreign people or people who live outside the hospital's reference area.
- People with language difficulties.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Nombre de bras
Armes et Interventions
Groupe de participants / BrasGroupe de participants / Bras |
Intervention / TraitementIntervention / Traitement |
|---|---|
|
Expérimental: Educational group
In the case of the intervention group, a standardized, structured and more intense follow-up plan than usual will be applied. |
This next step will begin after discharge from the hospital with a face-to-face visit from specialized nursing, in which a comprehensive assessment will be carried out, the administration of measurement scales, individualized health education and coordination of primary care and other assistance devices if necessary. |
|
Aucune intervention: control group
usual nursing care |
Que mesure l'étude ?
Principaux critères de jugement
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of patients with nursing intervention who need hospital admission in a year
Délai: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see how many times they have been admitted for heart failure decompensation. The number of admissions, the main admission diagnosis, and the number of days in the hospital will be reviewed |
From enrollment to the end of treatment at 12 months
|
|
Number of visits to the emergency room in the past year for patients who have undergone the nursing intervention
Délai: From enrollment to the end of treatment at 12 months
|
Review of the patient's medical history at the annual visit to see the number of emergency visits for heart failure decompensation. The number of visits to the emergency room, the reason for the visit, the main diagnosis at discharge, and the patient's destination will be checked |
From enrollment to the end of treatment at 12 months
|
Mesures de résultats secondaires
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Number of people with a good level of self-care according to the scale Self-Care of Heart Failure Index who have received intervention from the nurse
Délai: From enrollment to the end of treatment at 12 months
|
The questionnaire consists of 22 items spread across three independent scales that assess the patient's behaviors over the past month. The items are answered using a four-point Likert scale. The scores for each scale are calculated separately and converted into standardized values from 0 to 100, where higher scores indicate a better level of self-care. A score of 70 or above is considered indicative of adequate self-care. |
From enrollment to the end of treatment at 12 months
|
Collaborateurs et enquêteurs
Parrainer
Parrainer
Les enquêteurs
Les enquêteurs
- Directeur d'études: Maria Rosa Suñer Soler, RN, PhD, Universitat de Girona
- Chaise d'étude: Aurora Fontova Almató, RN, PhD, Fundacio Salut Emporda
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Début de l'étude
Achèvement primaire (Estimé)
Achèvement primaire
Achèvement de l'étude (Estimé)
Achèvement de l'étude
Dates d'inscription aux études
Première soumission
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Première publication
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour publiée
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
Autres numéros d'identification d'étude
- 2026.145
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
It is a single-center study that does not intend to share information with third parties and will only publish the research results.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .